Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$31.26

1.18 (3.92%)

11:31
01/10/17
01/10
11:31
01/10/17
11:31

Baird expects Sarepta 'relief rally' on launch update

Baird analyst Brian Skorney expects a "relief rally" in shares of Sarepta Therapeutics after the company announced Exondys 51 sales of $5.4M and greater than 250 patient start forms were submitted by year-end. If the shares were at $60, the sales figure would be a disappointment, but expectations have been lowered and whisper numbers were nearing negative territory, Skorney tells investors in a research note following Sarepta's JPMorgan Conference presentation. "This is just the beginning," as the company has dystrophin data coming from SRP-4053 in exon-53-amenable patients in the first half of 2017 and data plans to advance at least three additional assets, the analyst contends. Skorney keeps an Outperform rating on Sarepta with a $102 price target.

  • 10

    Jan

SRPT Sarepta
$31.26

1.18 (3.92%)

12/22/16
JPMS
12/22/16
INITIATION
Target $40
JPMS
Overweight
Sarepta initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Sarepta Therapeutics with an Overweight rating and $40 price target. The stock is down over 50% since the September approval of Exondys 51 for the treatment of Exon 51 Duchenne muscular dystrophy, Rama tells investors in a research note. The analyst believes that while shares could be range-bound in the first half of 2017 amid a "conservative launch trajectory" relative to consensus expectations, Sarepta "could be poised for a rebound" in the second half of the year as it works work with payers and provides greater clarity. He thinks "patience will be required" for Sarepta investors.
12/22/16
12/22/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Microsoft (MSFT) initiated with an Overweight at Piper Jaffray. 2. Sarepta (SRPT) initiated with an Overweight at JPMorgan. 3. Oracle (ORCL) initiated with an Overweight at MUFG. 4. Zillow (Z, ZG) initiated with a Hold at Stifel. 5. Las Vegas Sands (LVS) was initiated with a Buy and Wynn Resorts (WYNN) was initiated with a Neutral at Aegis. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/23/16
OPCO
12/23/16
NO CHANGE
Target $76
OPCO
Outperform
Oppenheimer remains bullish on Sarepta
Oppenheimer analyst Hartaj Singh notes that Sarepta has a commercial and active product in Exondys 51 for Exon 51 amenable Duchenne muscular dystrophy, a disease with a high unmet need. The analyst believes that a "complex reimbursement environment" coupled with a small target patient population in the U.S. could lead to a slower launch than expected. However, once the reimbursement process is settled and the patient on-boarding process is efficient, he expects a stronger sales ramp. Singh remains bullish on the stock, and reiterates an Outperform rating and $76 price target on the shares.
01/06/17
JMPS
01/06/17
NO CHANGE
Target $65
JMPS
Outperform
Sarepta price target lowered to $65 after physician survey at JMP Securities
JMP Securities analyst Liisa Bayko reported the firm conducted its first survey of U.S. physicians who treat Duchenne muscular dystrophy patients to gauge early experiences with Sarepta's Exondys 51. At the end of 2016, respondents had written a prescription to about 1 in 5 eligible patients, 1 in 5 were denied coverage and about 15% were in the adjudication process, noted Bayko, who lowered her price target on Sarepta to $65 from $90 to adjust for the survey results as well as an updated pricing analysis. Bayko keeps an Outperform rating on Sarepta and said she sees potential upside to about $160 per share if Exondys 51 is approved in the EU and if all of its earlier-stage assets targeting exons 45/53 are successful.

TODAY'S FREE FLY STORIES

AKER

Akers Biosciences

$2.15

0.2 (10.26%)

16:28
03/30/17
03/30
16:28
03/30/17
16:28
Syndicate
Akers Biosciences announces $2M private placement »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Mar

FC

Franklin Covey

$16.05

0.1 (0.63%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Hot Stocks
Franklin Covey says affirms FY17 guidance »

Says "the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

XLNX

Xilinx

$57.88

-0.14 (-0.24%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Initiation
Xilinx initiated  »

Xilinx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$15.61

-0.13 (-0.83%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Initiation
Marvell initiated  »

Marvell initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

NRE

Northstar Realty Europe Corp.

$11.63

0.02 (0.17%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Hot Stocks
Northstar Realty Europe Corp. CFO Scott Berry to resign, effective May 10 »

On March 27, Scott Berry,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$57.20

-0.16 (-0.28%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Initiation
Qualcomm initiated  »

Qualcomm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.41

-0.24 (-0.17%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Periodicals
Oculus co-founder and Rift creator Palmer Luckey leaves Facebook, Upload says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$69.08

1.23 (1.81%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Initiation
Qorvo initiated  »

Qorvo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

NFX

Newfield Exploration

$36.71

0.41 (1.13%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Hot Stocks
Newfield Exploration to build new water recycling facility in Oklahoma »

Newfield Exploration has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

TXN

Texas Instruments

$81.04

0.55 (0.68%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
Texas Instruments initiated  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 09

    May

NVDA

NVIDIA

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
NVIDIA initiated  »

NVIDIA initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

FC

Franklin Covey

$16.05

0.1 (0.63%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Earnings
Franklin Covey reports Q2 EPS (24c), consensus (22c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

AMD

AMD

$14.05

0.34 (2.48%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
AMD initiated  »

AMD initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$876.34

2.02 (0.23%)

, WMT

Wal-Mart

$71.59

0.85 (1.20%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
General news
On The Fly: Top stock stories for Thursday »

Stock advanced, with the…

AMZN

Amazon.com

$876.34

2.02 (0.23%)

WMT

Wal-Mart

$71.59

0.85 (1.20%)

LULU

lululemon

$50.76

-15.54 (-23.44%)

COP

ConocoPhillips

$50.00

4.05 (8.81%)

GIS

General Mills

$59.07

-0.37 (-0.62%)

MDLZ

Mondelez

$43.28

-0.47 (-1.07%)

TGT

Target

$55.25

0.1 (0.18%)

COST

Costco

$167.89

0.46 (0.27%)

PG

Procter & Gamble

$90.20

-0.4 (-0.44%)

UN

Unilever; also tag UL

$49.86

-0.48 (-0.95%)

UL

Unilever; also tag UN

$49.63

-0.43 (-0.86%)

PEP

PepsiCo

$112.18

-0.25 (-0.22%)

KMB

Kimberly-Clark

$132.24

-0.29 (-0.22%)

CVE

Cenovus Energy

$11.29

-1.79 (-13.69%)

FCX

Freeport McMoRan

$13.31

0.59 (4.64%)

EXTR

Extreme Networks

$7.38

0.92 (14.24%)

BRCD

Brocade

$12.44

0.01 (0.08%)

AVGO

Broadcom

$220.04

-1.27 (-0.57%)

PVTB

PrivateBancorp

$59.00

2.8 (4.98%)

CM

CIBC

$85.31

-2.61 (-2.97%)

CRBP

Corbus Pharmaceuticals

$7.95

-1.05 (-11.67%)

WOR

Worthington

$45.97

-4.66 (-9.20%)

SCWX

SecureWorks

$9.68

-0.65 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 06

    Apr

  • 06

    Apr

  • 26

    Apr

  • 29

    Apr

  • 09

    May

  • 16

    May

  • 02

    Jun

  • 06

    Jun

  • 20

    Jun

  • 30

    Oct

  • 30

    Mar

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Conference/Events
Federal Reserve Bank of New York President speaks on financial conditions »

New York Federal Reserve…

NH

NantHealth

$5.09

0.13 (2.62%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Earnings
NantHealth reports Q4 adjusted EPS (18c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

  • 06

    Jun

CAVM

Cavium

$71.47

0.11 (0.15%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Cavium initiated  »

Cavium initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

  • 09

    May

SWKS

Skyworks

$98.14

0.91 (0.94%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Skyworks initiated  »

Skyworks initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

  • 30

    May

AVGO

Broadcom

$220.04

-1.27 (-0.57%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Broadcom initiated  »

Broadcom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

MXIM

Maxim Integrated

$44.92

0.15 (0.34%)

16:23
03/30/17
03/30
16:23
03/30/17
16:23
Initiation
Maxim Integrated initiated  »

Maxim Integrated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$35.75

0.18 (0.51%)

16:23
03/30/17
03/30
16:23
03/30/17
16:23
Initiation
Intel initiated  »

Intel initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

  • 27

    Apr

  • 02

    May

DRIO

DarioHealth

$3.90

-0.0899 (-2.25%)

16:21
03/30/17
03/30
16:21
03/30/17
16:21
Syndicate
DarioHealth announces offering of common stock, no amount given »

Aegis Capital Corp. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$11.61

0.19 (1.66%)

16:21
03/30/17
03/30
16:21
03/30/17
16:21
Options
Closing CBOE SPX and VIX Index summary for March 30th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$28.97

0.47 (1.65%)

16:21
03/30/17
03/30
16:21
03/30/17
16:21
Initiation
Micron initiated  »

Micron initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

MULE

MuleSoft

$23.71

-0.09 (-0.38%)

16:20
03/30/17
03/30
16:20
03/30/17
16:20
Hot Stocks
Breaking Hot Stocks news story on MuleSoft »

Bain Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.